NO983990D0 - Aminotetralin-derivater og blandinger og metode for anvendelse derav - Google Patents

Aminotetralin-derivater og blandinger og metode for anvendelse derav

Info

Publication number
NO983990D0
NO983990D0 NO983990A NO983990A NO983990D0 NO 983990 D0 NO983990 D0 NO 983990D0 NO 983990 A NO983990 A NO 983990A NO 983990 A NO983990 A NO 983990A NO 983990 D0 NO983990 D0 NO 983990D0
Authority
NO
Norway
Prior art keywords
hydrogen
mixtures
aminotetralin derivatives
alkoxy
halogen
Prior art date
Application number
NO983990A
Other languages
English (en)
Norwegian (no)
Other versions
NO983990L (no
Inventor
Edward John Warawa
Bernard Migler
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO983990L publication Critical patent/NO983990L/no
Publication of NO983990D0 publication Critical patent/NO983990D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO983990A 1996-03-01 1998-08-31 Aminotetralin-derivater og blandinger og metode for anvendelse derav NO983990D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1264096P 1996-03-01 1996-03-01
PCT/GB1997/000516 WO1997031887A1 (en) 1996-03-01 1997-02-25 Aminotetralin derivatives and compositions and method of use thereof

Publications (2)

Publication Number Publication Date
NO983990L NO983990L (no) 1998-08-31
NO983990D0 true NO983990D0 (no) 1998-08-31

Family

ID=21755962

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983990A NO983990D0 (no) 1996-03-01 1998-08-31 Aminotetralin-derivater og blandinger og metode for anvendelse derav

Country Status (14)

Country Link
US (1) US5807897A (de)
EP (1) EP0883599B1 (de)
JP (1) JP4083221B2 (de)
KR (1) KR19990087369A (de)
CN (1) CN1212682A (de)
AT (1) ATE218535T1 (de)
AU (1) AU733264B2 (de)
DE (1) DE69713067T2 (de)
IL (1) IL125907A0 (de)
NO (1) NO983990D0 (de)
NZ (1) NZ330974A (de)
TW (1) TW409113B (de)
WO (1) WO1997031887A1 (de)
ZA (1) ZA971670B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726736D0 (en) 1997-12-18 1998-02-18 Zeneca Ltd Chemical compounds
JP2002533447A (ja) * 1998-12-24 2002-10-08 アストラゼネカ・アクチエボラーグ 神経疾患の治療に有用な1,4−ジアザシクロヘプタン誘導体
GB9914015D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
GB9914025D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
GB9914024D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
CA2536073A1 (en) * 2003-08-18 2005-02-24 H. Lundbeck A/S Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
TWI453198B (zh) * 2005-02-16 2014-09-21 Lundbeck & Co As H 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
TWI376373B (en) * 2005-02-16 2012-11-11 Lundbeck & Co As H Crystalline base of a pharmaceutical compound
MX2010012037A (es) * 2008-05-07 2010-11-30 Lundbeck & Co As H Composiciones y uso utiles para tratar trastornos cognitivos.
JP2012504560A (ja) * 2008-10-03 2012-02-23 ハー・ルンドベック・アクチエゼルスカベット 経口製剤
JP2024520832A (ja) 2021-06-08 2024-05-24 エンセオジェニックス バイオサイエンシズ, インコーポレイテッド セロトニン受容体のジメトキシフェニルアルキルアミン活性化剤
CA3242479A1 (en) 2021-12-27 2023-07-06 Atai Therapeutics, Inc. AMINOTERALINE SEROTONIN RECEPTOR ACTIVATORS
US12343319B2 (en) 2023-05-01 2025-07-01 Atai Therapeutics, Inc. Compositions and methods for treatment of diseases and disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320148A (en) * 1980-11-24 1982-03-16 Smithkline Corporation 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
SE8904127D0 (sv) * 1989-12-07 1989-12-07 Astra Ab New biocyclic amino-substituted compounds
EP0450238A1 (de) * 1990-03-30 1991-10-09 Merrell Dow Pharmaceuticals Inc. Verbindungen für die Behandlung von Migräne

Also Published As

Publication number Publication date
NO983990L (no) 1998-08-31
WO1997031887A1 (en) 1997-09-04
ZA971670B (en) 1997-09-01
AU1887997A (en) 1997-09-16
NZ330974A (en) 2000-05-26
US5807897A (en) 1998-09-15
EP0883599A1 (de) 1998-12-16
TW409113B (en) 2000-10-21
JP2000506137A (ja) 2000-05-23
CN1212682A (zh) 1999-03-31
AU733264B2 (en) 2001-05-10
KR19990087369A (ko) 1999-12-27
ATE218535T1 (de) 2002-06-15
EP0883599B1 (de) 2002-06-05
JP4083221B2 (ja) 2008-04-30
DE69713067D1 (de) 2002-07-11
DE69713067T2 (de) 2002-12-19
IL125907A0 (en) 1999-04-11

Similar Documents

Publication Publication Date Title
CA2432085A1 (en) Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
CA2387517A1 (en) Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
GB0005251D0 (en) Therapeutic compounds
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
LU91751I2 (fr) Asenapin et ses dérivés pharmaceutiquement acceptables (SYCREST®)
HUP0400365A2 (hu) 3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
YU191491A (sh) Nova so 3- 2-(dimetilamino)etil -n-metil-14-indol-5-metansulfonamida
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
IL125907A0 (en) Aminotetralin derivatives and compositions and method of use thereof
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
NO985979D0 (no) 1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse
MX9708595A (es) Derivados de bencil piperidina como agentes farmaceuticos.
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
CA2113916A1 (en) 6-Chloro-5-Fluoro-3-(2-Thenoyl)-2-Oxindole-1-Carboxamide as an Analgesic and Anti-Inflammatory Agent
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
LV11728A (lv) Farmaceitiska kompozicija
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
RU94046144A (ru) Замещенные (арилалкиламинобензил) аминопропионамидные производные, их применение, способы их получения, фармкомпозиция
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
AP9801235A0 (en) Erythromycin derivatives.
AP2002002595A0 (en) Heterocyclic amide derivatives.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
DK0401093T3 (da) Hidtil ukendte pyrrolidonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application